112 related articles for article (PubMed ID: 1084156)
1. Pyoderma gangrenosum with cellular immunity deficit treated with plasmaphoresis and leukocyte transfusion.
Clayton R; Feiwel M; Valdimarsson H
Br J Dermatol; 1976 Jul; 95 Suppl 14():67-8. PubMed ID: 1084156
[No Abstract] [Full Text] [Related]
2. Pyoderma gangrenosum with cellular immunity defect and red cell aplasia.
Clayton R
Proc R Soc Med; 1977 Aug; 70(8):571-2. PubMed ID: 303364
[No Abstract] [Full Text] [Related]
3. Pyoderma gangrenosum vs malignant pyoderma. Lumpers vs splitters.
Malkinson FD
Arch Dermatol; 1987 Mar; 123(3):333-7. PubMed ID: 3545089
[No Abstract] [Full Text] [Related]
4. [Dermatitis ulcerosa (pyoderma gangraenosum). 2 cases with abnormal serum factors].
Kovács L; Husz S; Dobozy A; Szarbó E
Z Hautkr; 1976 May; 51(09):571-81. PubMed ID: 785845
[No Abstract] [Full Text] [Related]
5. Present status of pyoderma gangrenosum. Review of 21 cases.
Prystowsky JH; Kahn SN; Lazarus GS
Arch Dermatol; 1989 Jan; 125(1):57-64. PubMed ID: 2642682
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum with altered cellular immunity and dermonecrotic factor.
Delescluse J; De Bast C; Achten G
Br J Dermatol; 1972 Dec; 87(6):529-32. PubMed ID: 4567639
[No Abstract] [Full Text] [Related]
7. Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of azathioprine and corticosteroid therapy.
Breathnach SM; Wells GC; Valdimarsson H
Br J Dermatol; 1981 May; 104(5):567-73. PubMed ID: 7236516
[TBL] [Abstract][Full Text] [Related]
8. Direct immunofluorescence in pyoderma gangrenosum.
Powell FC; Schroeter AL; Perry HO; Su WP
Br J Dermatol; 1983 Mar; 108(3):287-93. PubMed ID: 6338899
[TBL] [Abstract][Full Text] [Related]
9. [Chronic vegetating pyodermia in cellular immune deficiency].
Brachtel R; Lemmel EM
Hautarzt; 1976 Oct; 27(10):488-91. PubMed ID: 1086850
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen therapy for pyoderma gangrenosum.
Thomas CY; Crouch JA; Guastello J
Arch Dermatol; 1974 Sep; 110(3):445-6. PubMed ID: 4451395
[No Abstract] [Full Text] [Related]
11. Hyperimmunoglobulin E and impaired neutrophil functions in a case of pyoderma gangrenosum: effect of clofazimine.
Berbis P; Mege JL; Capo C; Kaplanski S; Bongrand P; Privat Y
J Am Acad Dermatol; 1988 Mar; 18(3):574-6. PubMed ID: 3351016
[No Abstract] [Full Text] [Related]
12. The current status of pyoderma gangrenosum.
Holt PJ
Clin Exp Dermatol; 1979 Dec; 4(4):509-16. PubMed ID: 394888
[No Abstract] [Full Text] [Related]
13. Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.
Jones RR; Kobza Black A; Donaghy M; Moshtael O; Pinching AJ
Clin Exp Immunol; 1983 Jun; 52(3):685-92. PubMed ID: 6409473
[TBL] [Abstract][Full Text] [Related]
14. [Pyoderma gangrenosum (dermatitis ulcerosa)].
Bäurle G; Weidner F
Z Hautkr; 1975 Oct; 50(19):827-8. PubMed ID: 1106012
[No Abstract] [Full Text] [Related]
15. Pyoderma gangrenosum with a monoclonal IgM red cell agglomerating factor.
Cream JJ
Br J Dermatol; 1971 Mar; 84(3):223-6. PubMed ID: 5572674
[No Abstract] [Full Text] [Related]
16. Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum.
Johnson RB; Lazarus GS
Arch Dermatol; 1982 Feb; 118(2):76-84. PubMed ID: 7036913
[No Abstract] [Full Text] [Related]
17. New look at pyoderma gangrenosum.
Shore RN
Cutis; 1977 Aug; 20(2):209-13, 217-9. PubMed ID: 891244
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone.
Norris DA; Weston WL; Thorne G; Humbert JR
Arch Dermatol; 1978 Jun; 114(6):906-11. PubMed ID: 666327
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum.
Wolk BH
Am Fam Physician; 1982 Aug; 26(2):177-9. PubMed ID: 7102495
[TBL] [Abstract][Full Text] [Related]
20. Letter: Pyoderma gangrenosum.
Dantzig PI
N Engl J Med; 1975 Jan; 292(1):47-8. PubMed ID: 1088921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
